Navigation Links
Drug That Is Found To Reduce Heart Damage from Chemo

A potent chemotherapy that is highly effective in treating the most common form of childhood leukemia can significantly harm the heart. However, new research shows // that adding an experimental drug to the therapy can reduce or even prevent the heart damage without lessening the effect of the chemotherapy.

Researchers say if long term studies confirm their results, this would be the first strategy proven to reduce the heart problems that some acute lymphoblastic leukemia survivors develop years after being treated with doxorubicin (Adriamycin).

For the study, 101 participants were treated with doxorubicin alone. Another 105 participants received doxorubicin with dexrazoxane (Zinecard), an experimental drug shown to be cardioprotective in adults who receive chemotherapy. Half of the children in the doxorubicin-only group had elevated levels of troponin T, a protein that is elevated when the heart has been injured. In the children who received the combination, only 21 percent had elevated troponin T levels.

Extremely elevated troponin T levels, indicating more severe heart-muscle injury, occurred in 32 percent of the doxorubicin-only patients but in just 10 percent of those who received the protective drug. In addition, dexrazoxane did not reduce doxorubicin’s ability to cure the children.

However researchers say this is not a perfect solution but it is promising as it is found to reduce the incidence of heart damage from 50 percent to about 25 percent with dexrazoxane .
'"/>




Page: 1

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... ... is proud to announce that it has received 510(k) clearance from the U.S. ... Home and the MyoCycle Pro. , Both devices are stationary cycling systems that ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... an agreement to be the preferred physical therapy provider for Derby City CrossFit, ... to Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Lake Park ... smiles by using Invisalign® in Lutz, FL. With the help of this ... and aesthetics with fewer potential complications, more discretion and less pain. , Drs. ...
(Date:4/25/2017)... ... April 25, 2017 , ... As Spring reignites vigilance ... research related to Zika virus during pregnancy, as well as other prenatal exposures ... science. , The Teratology Society is an international and multidisciplinary ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive ... offering. ... market was valued at US$ 7,167.6 Mn in 2015, and ... at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: